These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 3520418

  • 1. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
    Huber H, Thaler J, Greil R, Gattringer C, Radaszkiewicz T.
    Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
    [Abstract] [Full Text] [Related]

  • 2. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H, Gattringer C, Thaler J, Peschel C.
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [Abstract] [Full Text] [Related]

  • 3. Immunopathology of non-Hodgkin lymphomas.
    Huber H, Gattringer C, Knapp W, Stein H.
    Klin Wochenschr; 1984 Nov 02; 62(21):1001-10. PubMed ID: 6392723
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic and prognostic value of immunohistological bone marrow examination: results in 212 patients with lymphoproliferative disorders.
    Thaler J, Denz H, Gattringer C, Glassl H, Lechleitner M, Dietze O, Huber H.
    Blut; 1987 Apr 02; 54(4):213-22. PubMed ID: 3103722
    [Abstract] [Full Text] [Related]

  • 5. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H.
    Immun Infekt; 1976 Apr 02; 4(2):52-69. PubMed ID: 1085745
    [Abstract] [Full Text] [Related]

  • 6. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D, Bonati A, Giardini R, Villa S, De Braud F, Cattoretti G, Rilke F.
    Hematol Oncol; 1986 Apr 02; 4(3):237-48. PubMed ID: 3095211
    [Abstract] [Full Text] [Related]

  • 7. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T, Laurent G, Caveriviere P, Rigal F, Delsol G.
    Clin Exp Immunol; 1984 Dec 02; 58(3):631-8. PubMed ID: 6239721
    [Abstract] [Full Text] [Related]

  • 8. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA, Bailey D, Stansfeld AG, Greaves MF.
    Br J Cancer; 1983 Mar 02; 47(3):327-51. PubMed ID: 6338896
    [Abstract] [Full Text] [Related]

  • 9. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW.
    Veroff Pathol; 1986 Mar 02; 123():1-241. PubMed ID: 3518274
    [Abstract] [Full Text] [Related]

  • 10. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA, Catley PF, Stansfeld AG, Brearley RL.
    Br J Cancer; 1979 Jul 02; 40(1):11-34. PubMed ID: 314300
    [Abstract] [Full Text] [Related]

  • 11. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS, Nadler LM.
    Hematol Oncol Clin North Am; 1991 Oct 02; 5(5):871-89. PubMed ID: 1938759
    [Abstract] [Full Text] [Related]

  • 12. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A.
    Leukemia; 2002 Aug 02; 16(8):1460-9. PubMed ID: 12145686
    [Abstract] [Full Text] [Related]

  • 13. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
    Harris NL, Nadler LM, Bhan AK.
    Am J Pathol; 1984 Nov 02; 117(2):262-72. PubMed ID: 6437232
    [Abstract] [Full Text] [Related]

  • 14. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
    Smith JL, Jones DB, Bell AJ, Wright DH.
    Hematol Oncol; 1989 Nov 02; 7(1):37-48. PubMed ID: 2642457
    [Abstract] [Full Text] [Related]

  • 15. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
    Porwit-Ksiazek A, Christensson B, Lindemalm C, Mellstedt H, Tribukait B, Biberfeld G, Biberfeld P.
    Int J Cancer; 1983 Dec 15; 32(6):667-74. PubMed ID: 6317576
    [Abstract] [Full Text] [Related]

  • 16. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G, Bartels H, Common H, Dühmke E, Fülle HH, Gunzer U, Gyenes T, Heinz R, König E, Meusers P.
    Hematol Oncol; 1984 Dec 15; 2(3):269-306. PubMed ID: 6384008
    [Abstract] [Full Text] [Related]

  • 17. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
    Wessel H.
    Arch Geschwulstforsch; 1979 Dec 15; 49(8):635-47. PubMed ID: 317425
    [Abstract] [Full Text] [Related]

  • 18. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G, Al Saati T, Caveriviere P, Voigt JJ, Ancelin E, Rigal-Huguet F.
    Ann Pathol; 1984 Dec 15; 4(3):165-83. PubMed ID: 6383412
    [Abstract] [Full Text] [Related]

  • 19. Incidence and histological features of bone marrow involvement in malignant lymphomas.
    Lambertenghi-Deliliers G, Annaloro C, Soligo D, Oriani A, Pozzoli E, Quirici N, Luksch R, Polli EE.
    Ann Hematol; 1992 Aug 15; 65(2):61-5. PubMed ID: 1324741
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.